Sunshine Biopharma, Inc. (SBFM) vs China SXT Pharmaceuticals, Inc. (SXTC)
- Sunshine Biopharma, Inc. SBFM 0.22 −4.35%
- China SXT Pharmaceuticals, Inc. SXTC 0.07 0.00%
Sunshine Biopharma, Inc. and China SXT Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Sunshine Biopharma, Inc. is the larger, with a market value of $990.0K against $710.0K — 1.4× the size. Sunshine Biopharma, Inc. grew revenue faster over the last twelve months: −2.74% against −54.0%. Sunshine Biopharma, Inc. has the higher net margin (−16.5% vs −255.2%) and the lower return on invested capital (−26.7% vs 0.00%). Across the 17 metrics below, China SXT Pharmaceuticals, Inc. leads on 10 and Sunshine Biopharma, Inc. on 7.
Valuation
| Metric | SBFM | SXTC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| P/E | n/m | n/m | 19.25 |
| P/S | 0.01 | n/m | 2.11 |
| P/B | 0.01 | n/m | 1.78 |
| Price to free cash flow | n/m | n/m | 16.14 |
| EV/EBITDA | 2.38 | 2.66 | 12.58 |
| EV/Sales | (0.33) | (5.94) | 2.73 |
| Earnings yield | (4,613.64%) | (159,014.29%) | (4.38%) |
| Free cash flow yield | (1,843.25%) | 0.00% | 0.00% |
Profitability
| Metric | SBFM | SXTC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 30.30% | 36.69% | 53.94% |
| Operating margin | (16.65%) | 0.00% | 0.00% |
| Net margin | (16.50%) | (255.16%) | 0.00% |
| Free cash flow margin | (15.66%) | 0.00% | 0.00% |
| Return on equity | (21.93%) | 0.00% | (0.40%) |
| Return on assets | (17.78%) | 0.00% | (3.32%) |
| Return on invested capital | (26.67%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack